Malaria Vaccine Offers Hope In Overcoming 'Clinical Trials Labyrinth'

In this post in the Center for Global Development’s “Global Health Policy” blog, Amanda Glassman, the director of Global Health Policy and a research fellow at the center, and Thomas Bollyky, a former research fellow at the center, write that this month’s announcement that “an experimental vaccine cuts in half the risk of malaria in children in Africa is a welcome success story 20+ years in the making” and is “also a rare bright spot in the clinical trials labyrinth that stands between promising new medicines, vaccines, and diagnostic techniques and the one billion people in the developing world who suffer from one or more neglected diseases” (10/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.